Pfizer

Issued by Global Policy & Public Affairs, Pfizer Inc. -- Do Not Detail --
April 2023
Position on Expanded Access to Investigational Gene Therapies

Background

Gene therapy is a new generation of treatment with the potential to offer meaningful improvements for patients.
This new technology may address the underlying causes of disease but requires finding answers to new and
challenging development and delivery questions.

Pfizer’s ability to answer these questions relies on...